Arkolith/Insider Trading/CLDX/Form 4

Jimenez Freddy A.

SVP & GENERAL COUNSELCelldex Therapeutics, Inc. (CLDX) · full profile →Form 4 · filed Aug 15, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$19K
Net Open-Market Flow
-$19K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 13, 2025Sell(S)341$23.95$8K35K
Aug 13, 2025Sell(S)430$25.42$11K35K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-022069) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML